1. Health‐related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO‐2 trial12. Issue 10 (15th March 2013) Authors: Burris, Howard A.; Lebrun, Fabienne; Rugo, Hope S.; Beck, J. Thaddeus; Piccart, Martine; Neven, Patrick; Baselga, Jose; Petrakova, Katarina; Hortobagyi, Gabriel N.; Komorowski, Anna; Chouinard, Edmond; Young, Robyn; Gnant, Michael; Pritchard, Kathleen I.; Bennett, Lee; Ricci, Jean‐Francois; Bauly... Journal: Cancer Issue: Volume 119:Issue 10(2013) Page Start: 1908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Health‐related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO‐2 trial12. Issue 10 (15th March 2013) Authors: Burris, Howard A.; Lebrun, Fabienne; Rugo, Hope S.; Beck, J. Thaddeus; Piccart, Martine; Neven, Patrick; Baselga, Jose; Petrakova, Katarina; Hortobagyi, Gabriel N.; Komorowski, Anna; Chouinard, Edmond; Young, Robyn; Gnant, Michael; Pritchard, Kathleen I.; Bennett, Lee; Ricci, Jean‐Francois; Bauly... Journal: Cancer Issue: Volume 119:Issue 10(2013) Page Start: 1908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗